Alba Therapeutics Presents Data From Positive Phase Ib Clinical Trial At The XII International Celiac Disease Symposium
14th Nov 2006, 13:31 GMT
Data presented on November 11th at the XII International Celiac Disease Symposium in New York City show that when AT- 1001, an investigational oral zonulin receptor antagonist being developed for treatment of Celiac Disease ("CD"), was assessed in a double blind, placebo controlled study of C [click link for full article]
Alba Therapeutics Presents Data From Positive Phase Ib Clinical Trial At The XII International Celiac Disease Symposium related news:
- Overweight in Celiac Disease: Prevalence, Clinical Characteristics, and Effect of a Gluten-Free Diet — Medscape Headlines
- ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus — PR Newswire: All Releases
- Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus — PR Newswire: All Releases
- ZymoGenetics, Serono See Positive Data — Bio-Technology News from StratCenter.com
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years — EurekAlert! - Medicine and Health
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma — Bio-Technology News from StratCenter.com
- ZymoGenetics, Serono present positive results for atacicept — Pharmaceutical Business Review Latest News
- Corcept Therapeutics Completes Enrollment In Third Phase 3 Study For Treating Psychotic Major Depression — Health News from Medical News Today
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting — Partnerships/ Joint Ventures News from StratCenter.com
- Neurogen's obesity drug in phase 1 trial — United Press International - Health Business
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes